Lindsay Edwards
CTO, Relation Therapeutics Ltd.
Lindsay Edwards is listed as CTO, Relation Therapeutics Ltd.. B2DB records 2 sessions at 1 conference in 2026, most recently Drug Discovery Chemistry Europe 2026 (November 2026). Speaks mainly at Hospitals and Health Care events.
Compiled from published conference agendas; not yet confirmed by Lindsay. Is this you? Claim this profile.
- Sector: Hospitals and Health Care
About
Lindsay is an internationally recognised leader at the interface of machine learning, computational biology, and drug discovery. He has served in senior roles in Fortune 500 companies (including GSK and AstraZeneca) and is currently CTO and President of Platform at Relation. He provides academic depth with a delivery focus and has led and scaled a range of organisations. He is currently a Scientific Advisor at The Broad Institute of MIT / Harvard. He was recently elected a Fellow of the Academy of Medical Sciences.
Sessions at 1 conference
Drug Discovery Chemistry Europe 2026 11 November 2026 – 12 November 2026
- Panel Discussion: From Molecules to Medicines: How AI Foundation Models are Reshaping Drug Discovery Panellist · 11 November 2026
- Three Impactful Problems in Drug Discovery That Might be Solvable with Machine Learning Speaker · 11 November 2026
Spoke alongside
People who have shared a session with Lindsay at events on B2DB.
- Ashwini Ghogare GenAI Leader for Start-ups, Life Sciences and Healthcare · Amazon Web Services 1 shared session
- Steven Crossan CEO & Founder · Dayhoff Labs 1 shared session
- Fanny Jaulin CEO & Cofounder · Orakl Oncology 1 shared session
- Gustave Ronteix Co-Founder and CTO · Orakl Oncology 1 shared session
- Iva Lukac Director of AI in Drug Discovery · Apheris 1 shared session
- Jeremy Wohlwend CTO · Boltz 1 shared session